TY - JOUR
T1 - Reproductive factors, hormonal interventions, and gastric cancer risk in the Stomach cancer Pooling (StoP) Project
AU - Song, Minkyo
AU - Jayasekara, Harindra
AU - Pelucchi, Claudio
AU - Rabkin, Charles S.
AU - Johnson, Kenneth C.
AU - Hu, Jinfu
AU - Palli, Domenico
AU - Ferraroni, Monica
AU - Liao, Linda M.
AU - Bonzi, Rossella
AU - Zaridze, David
AU - Maximovitch, Dmitry
AU - Aragonés, Nuria
AU - Martin, Vicente
AU - Castaño-Vinyals, Gemma
AU - Guevara, Marcela
AU - Tsugane, Shoichiro
AU - Hamada, Gerson Shigueaki
AU - Hidaka, Akihisa
AU - Negri, Eva
AU - Ward, Mary H.
AU - Sinha, Rashmi
AU - Lagiou, Areti
AU - Lagiou, Pagona
AU - Boffetta, Paolo
AU - Curado, Maria Paula
AU - Lunet, Nuno
AU - Vioque, Jesus
AU - Zhang, Zuo Feng
AU - La Vecchia, Carlo
AU - Camargo, M. Constanza
N1 - Publisher Copyright:
© This is a U.S. Government work and not under copyright protection in the US; foreign copyright protection may apply 2023.
PY - 2024/4
Y1 - 2024/4
N2 - Background: Gastric cancer incidence is higher in men, and a protective hormone-related effect in women is postulated. We aimed to investigate and quantify the relationship in the Stomach cancer Pooling (StoP) Project consortium. Methods: A total of 2,084 cases and 7,102 controls from 11 studies in seven countries were included. Summary odds ratios (ORs) and 95% confidence intervals (CIs) assessing associations of key reproductive factors and menopausal hormone therapy (MHT) with gastric cancer were estimated by pooling study-specific ORs using random-effects meta-analysis. Results: A duration of fertility of ≥ 40 years (vs. < 20), was associated with a 25% lower risk of gastric cancer (OR = 0.75; 95% CI: 0.58–0.96). Compared with never use, ever, 5–9 years and ≥ 10 years use of MHT in postmenopausal women, showed ORs of 0.73 (95% CI: 0.58–0.92), 0.53 (95% CI: 0.34–0.84) and 0.71 (95% CI: 0.50–1.00), respectively. The associations were generally similar for anatomical and histologic subtypes. Conclusion: Our results support the hypothesis that reproductive factors and MHT use may lower the risk of gastric cancer in women, regardless of anatomical or histologic subtypes. Given the variation in hormones over the lifespan, studies should address their effects in premenopausal and postmenopausal women. Furthermore, mechanistic studies may inform potential biological processes.
AB - Background: Gastric cancer incidence is higher in men, and a protective hormone-related effect in women is postulated. We aimed to investigate and quantify the relationship in the Stomach cancer Pooling (StoP) Project consortium. Methods: A total of 2,084 cases and 7,102 controls from 11 studies in seven countries were included. Summary odds ratios (ORs) and 95% confidence intervals (CIs) assessing associations of key reproductive factors and menopausal hormone therapy (MHT) with gastric cancer were estimated by pooling study-specific ORs using random-effects meta-analysis. Results: A duration of fertility of ≥ 40 years (vs. < 20), was associated with a 25% lower risk of gastric cancer (OR = 0.75; 95% CI: 0.58–0.96). Compared with never use, ever, 5–9 years and ≥ 10 years use of MHT in postmenopausal women, showed ORs of 0.73 (95% CI: 0.58–0.92), 0.53 (95% CI: 0.34–0.84) and 0.71 (95% CI: 0.50–1.00), respectively. The associations were generally similar for anatomical and histologic subtypes. Conclusion: Our results support the hypothesis that reproductive factors and MHT use may lower the risk of gastric cancer in women, regardless of anatomical or histologic subtypes. Given the variation in hormones over the lifespan, studies should address their effects in premenopausal and postmenopausal women. Furthermore, mechanistic studies may inform potential biological processes.
KW - Estrogens
KW - MHT
KW - Postmenopause
KW - Premenopause
UR - https://www.scopus.com/pages/publications/85180190940
U2 - 10.1007/s10552-023-01829-1
DO - 10.1007/s10552-023-01829-1
M3 - Article
C2 - 38123742
AN - SCOPUS:85180190940
SN - 0957-5243
VL - 35
SP - 727
EP - 737
JO - Cancer Causes and Control
JF - Cancer Causes and Control
IS - 4
ER -